Stocktoria

Sana Biotechnology, Inc. SANA

Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-02-04

Sana Biotechnology, Inc. statistics & valuation

Market cap$951.8M
P / B5.9×
Return on equity-151.8%
Return on capital-74%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
202020212022202320242025
Operating margin (%)
202020212022202320242025
Return on equity (%)
-48.90% -54.00% -98.50% -106.50% -151.80% 202020212022202320242025
Shares outstanding
16.2M 184.9M 191.0M 197.9M 230.9M 266.7M 202020212022202320242025
Net debt ($)
202020212022202320242025
Share buybacks ($)
202020212022202320242025
Return on assets (%)
-39.10% -31.50% -32.80% -50.10% -53.20% -58.60% 202020212022202320242025
Free cash flow margin (%)
202020212022202320242025
Debt / equity (×)
202020212022202320242025
EPS ($)
-$21.92 -$2.14 -$1.43 -$1.46 -$1.16 -$0.96 202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020
Return on assets-58.6%-53.2%-50.1%-32.8%-31.5%-39.1%
Return on equity-151.8%-106.5%-98.5%-54.0%-48.9%67.7%
Current ratio1.893.543.313.995.6212.22

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.